Galectin Therapeutics, Inc. (GALT)
3.135
-0.16
(-4.71%)
USD |
NASDAQ |
Nov 12, 16:00
3.135
0.00 (0.00%)
After-Hours: 18:15
Galectin Therapeutics Price : 3.135 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 11, 2026 | 3.38 | 3.41 | 3.29 | 3.29 | 77984.00 |
| Nov 10, 2026 | 3.44 | 3.52 | 3.30 | 3.38 | 167707.0 |
| Nov 09, 2026 | 3.15 | 3.49 | 3.040 | 3.46 | 241213.0 |
| Nov 06, 2026 | 3.01 | 3.18 | 2.90 | 3.14 | 223444.0 |
| Nov 05, 2026 | 3.50 | 3.50 | 2.905 | 2.985 | 396605.0 |
| Nov 04, 2026 | 3.47 | 3.60 | 3.387 | 3.47 | 217509.0 |
| Nov 03, 2026 | 3.33 | 3.500 | 3.33 | 3.35 | 118235.0 |
| Nov 02, 2026 | 3.35 | 3.43 | 3.29 | 3.33 | 117165.0 |
| Oct 30, 2026 | 3.52 | 3.541 | 3.27 | 3.32 | 174747.0 |
| Oct 29, 2026 | 3.61 | 3.70 | 3.448 | 3.52 | 263871.0 |
| Oct 28, 2026 | 3.37 | 3.56 | 3.27 | 3.54 | 141163.0 |
| Oct 27, 2026 | 3.21 | 3.44 | 3.13 | 3.38 | 204734.0 |
| Oct 26, 2026 | 3.22 | 3.255 | 3.11 | 3.19 | 164392.0 |
| Oct 23, 2026 | 3.35 | 3.37 | 3.16 | 3.19 | 195220.0 |
| Oct 22, 2026 | 3.34 | 3.50 | 3.27 | 3.38 | 161536.0 |
| Oct 21, 2026 | 3.46 | 3.51 | 3.19 | 3.37 | 295685.0 |
| Oct 20, 2026 | 3.51 | 3.615 | 3.41 | 3.43 | 200201.0 |
| Oct 19, 2026 | 3.60 | 3.726 | 3.47 | 3.495 | 177288.0 |
| Oct 16, 2026 | 3.71 | 3.81 | 3.61 | 3.62 | 169431.0 |
| Oct 15, 2026 | 3.68 | 3.84 | 3.66 | 3.71 | 119199.0 |
| Oct 14, 2026 | 3.66 | 3.86 | 3.61 | 3.64 | 408977.0 |
| Oct 13, 2026 | 3.84 | 3.86 | 3.67 | 3.69 | 184438.0 |
| Oct 12, 2026 | 3.92 | 4.005 | 3.84 | 3.87 | 99681.00 |
| Oct 09, 2026 | 3.64 | 3.97 | 3.64 | 3.94 | 156508.0 |
| Oct 08, 2026 | 3.62 | 3.69 | 3.510 | 3.64 | 270887.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mirum Pharmaceuticals, Inc. | 93.26 |
| ACADIA Pharmaceuticals, Inc. | 18.12 |
| Alnylam Pharmaceuticals, Inc. | 156.59 |
| Anika Therapeutics, Inc. | 13.84 |
| Savara, Inc. | 4.71 |
Price Related Metrics
| Earnings Yield | -13.71% |
| Market Cap | 207.89M |